Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Glucagon Injection"'
Publikováno v:
JCRPE, Vol 13, Iss 3, Pp 285-292 (2021)
Journal of Clinical Research in Pediatric Endocrinology
Journal of Clinical Research in Pediatric Endocrinology
Objective: Hypoglycemia is a common acute complication of type 1 diabetes (T1D), which may cause seizure, loss of consciousness, and temporary motor or sensory impairment. Glucagon administration is an effective way of treating severe hypoglycemia, e
Autor:
Steven J. Prestrelski, Anh Nguyen, Khaled Junaidi, Martin J. Cummins, Nicole C. Close, Mark P. Christiansen
Publikováno v:
BMJ Open Diabetes Research & Care
IntroductionTo prevent medical sequelae of severe hypoglycemic emergencies, prompt and reliable rescue intervention is critically important. A ready-to-use, liquid stable glucagon, administered subcutaneously by glucagon autoinjector (GAI), Gvoke Hyp
Autor:
Ludmila Brunerová, Jan Brož, Denisa Janíčková Žďárská, Marisa A. Nunes, Martina Tuháčková, Jana Urbanová
Publikováno v:
Vnitřní lékařství. 65:295-299
Hypoglycemia is a side effect of the therapy primarily with insulin, sulphonylurea derivates and glinides. Its therapy is based on the immediate ingestion of sacharides, preferably glucose. Amount of 15-20 g is recommended as its optimal dose, althou
Publikováno v:
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. 27(4)
The prevalence of type 1 diabetes (T1D) in children is increasing. Adequate knowledge and skills of primary school staff are required to deal with children affected by T1D. We aimed to evaluate a video training program (VTP) to improve the level of c
Publikováno v:
Diabetes. 68
Aim: To compare sensor accuracy (Medtronic Enlite2®) after a subcutaneous (s.c) injection of low-dose glucagon near vs. remote from sensor site. Methods: Twelve adults with type 1 diabetes wore two continuous glucose monitors (CGMglucagon and CGMctr
Publikováno v:
Diabetes. 68
Glucagon injection is effective in the event of serious hypoglycemia, especially in unconscious patients who cannot swallow their medications. However, recent surveys in Japan found that only 15.9% of patients have glucagon injections in their posses
Autor:
Peng Du, Gregory O', null Grady, Niranchan Paskaranandavadivel, Shou-jiang Tang, Thomas Abell, Leo K Cheng
Publikováno v:
Journal of Neurogastroenterology and Motility
Background/Aims It is now recognised that gastric dysrhythmias are best characterised by their spatial propagation pattern. Hyperglycemia is an important cause of gastric slow wave dysrhythmia, however, the spatiotemporal patterns of dysrhythmias in
Autor:
Jay P. Farber, Jieyun Yin, Xinshou Ouyang, Lin Lin, Shiying Li, Robert D. Foreman, Jiande D. Z. Chen
Publikováno v:
Neurogastroenterology & Motility. 27:406-415
Background Hyperglycemia is known to induce dysrhythmias in the stomach; however, it is unknown whether they are also induced in the small intestine. Autonomic dysfunction is commonly noted in diabetes but the role it plays in hyperglycemia-induced d
Autor:
Jean-Marc Pequignot, Hervé Barré, Jean-Louis Rouanet, Y. Filali-Zegzouti, H. Abdelmelek, J. M. Cottet-Emard
Publikováno v:
Journal of Neural Transmission. 112:481-489
The present work was undertaken in order to investigate whether the observed thermogenesis following glucagon injection requires the participation of catecholamines. Our experiments aim at studying the effects of intraperitoneal injection of glucagon
Publikováno v:
Diabetes Technology & Therapeutics. 11:477-479
This article reevaluates the hypoglycemic episodes reported as severe in the Treat-to-Target Trial comparing insulin glargine and NPH insulin use in patients with inadequately controlled type 2 diabetes.Case report forms from the Treat-to-Target Tria